We are live on ! Find out more
ACM

AlphaCrest Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-16.78%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.07B
AUM Growth
+$283M
Cap. Flow
+$660M
Cap. Flow %
31.84%
Top 10 Hldgs %
6.27%
Holding
1,421
New
201
Increased
658
Reduced
377
Closed
185

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$18.6M
2
ADBE icon
Adobe
ADBE
+$13.3M
3
ORCL icon
Oracle
ORCL
+$11.8M
4
EA icon
Electronic Arts
EA
+$11.6M
5
NXPI icon
NXP Semiconductors
NXPI
+$11.1M

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$13.8M
2
IBM icon
IBM
IBM
+$11.3M
3
VZ icon
Verizon
VZ
+$10.8M
4
MS icon
Morgan Stanley
MS
+$9.99M
5
QCOM icon
Qualcomm
QCOM
+$9.34M

Sector Composition

Rank Sector Weight
1 Technology 18.47%
2 Financials 15.32%
3 Healthcare 13.31%
4 Industrials 11.81%
5 Consumer Discretionary 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
1226
Ford
F
$58.5B
$132K 0.01%
11,891
-43,446
-79% -$595K
FTI icon
1227
TechnipFMC
FTI
$28.1B
$129K 0.01%
19,214
-47,656
-71% -$363K
CHRS icon
1228
Coherus Oncology
CHRS
$217M
$128K 0.01%
+17,668
New +$154K
PLTR icon
1229
Palantir
PLTR
$295B
$127K 0.01%
14,040
-990
-7% -$9.79K
SABR icon
1230
Sabre
SABR
$731M
$114K 0.01%
19,600
-5,464
-22% -$45.6K
NEO icon
1231
NeoGenomics
NEO
$1.96B
$111K 0.01%
13,604
-2,920
-18% -$27.9K
ALEC icon
1232
Alector
ALEC
$168M
$106K 0.01%
10,400
-17,962
-63% -$179K
INFN
1233
DELISTED
Infinera Corporation Common Stock
INFN
$97K ﹤0.01%
18,121
-19,873
-52% -$127K
CYH icon
1234
Community Health Systems
CYH
$393M
$93K ﹤0.01%
+24,857
New +$175K
RWT
1235
Redwood Trust
RWT
$574M
$87K ﹤0.01%
+11,242
New +$103K
EQX icon
1236
Equinox Gold
EQX
$7.06B
$72K ﹤0.01%
16,318
-35,225
-68% -$228K
ACHC icon
1237
Acadia Healthcare
ACHC
$2.76B
-8,016
Closed -$525K
ACIW icon
1238
ACI Worldwide
ACIW
$5.83B
-37,625
Closed -$1.19M
AEO icon
1239
American Eagle Outfitters
AEO
$2.88B
-25,709
Closed -$432K
AER icon
1240
AerCap
AER
$23.7B
-13,043
Closed -$656K
AMBA icon
1241
Ambarella
AMBA
$3.77B
-3,054
Closed -$320K
APAM icon
1242
Artisan Partners
APAM
$2.79B
-7,176
Closed -$282K
APPN icon
1243
Appian
APPN
$1.98B
-3,978
Closed -$242K
ARI
1244
Apollo Commercial Real Estate
ARI
$867M
-15,301
Closed -$213K
ASAN icon
1245
Asana
ASAN
$1.92B
-11,039
Closed -$441K
ATRA icon
1246
Atara Biotherapeutics
ATRA
$75.5M
-852
Closed -$198K
ATRC icon
1247
AtriCure
ATRC
$1.92B
-5,219
Closed -$343K
AVPT icon
1248
AvePoint
AVPT
$2.76B
-46,100
Closed -$242K
BAND
1249
Bandwidth Inc
BAND
$1.26B
-18,376
Closed -$595K
BDN
1250
Brandywine Realty Trust
BDN
$524M
-24,016
Closed -$340K

Similar funds

AlphaCrest Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, AlphaCrest Capital Management held 1,421 positions worth $2.07B, up 16% from $1.79B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

AlphaCrest Capital Management deployed $660M of net new capital in Q2 2022, opening 201 new positions and adding to 658 existing holdings. Its largest new stake was UBS Group: 397,371 shares worth $6.45M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Lowe's Companies, an estimated $13.8M trimmed.

  • AlphaCrest Capital Management's largest Q2 2022 buy was UBS Group: 397,371 shares worth $6.45M.
  • AlphaCrest Capital Management added most to Target in Q2 2022, an estimated $18.6M increase.
  • AlphaCrest Capital Management's biggest Q2 2022 reduction was Lowe's Companies, cutting an estimated $13.8M.
  • AlphaCrest Capital Management fully exited PNC Financial Services in Q2 2022, selling an estimated $4.05M.
  • AlphaCrest Capital Management's ten largest holdings make up 6.3% of its $2.07B portfolio in Q2 2022.
  • AlphaCrest Capital Management opened 201 new positions and closed 185 in Q2 2022.
  • AlphaCrest Capital Management's portfolio value rose 16% quarter-over-quarter to $2.07B.

Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.